Veenat Imatinib – 100 mg, 400 mg Tablets

At a Glance

Brand name: Veenat

Generic name: Imatinib mesylate

Active ingredient: Imatinib

Strengths & packs: Veenat 100 mg (1 pack / 120 tablets); Veenat 400 mg (1 pack / 30 tablets)

Dosage form: Oral film-coated tablets

Main indication: Philadelphia chromosome–positive chronic myeloid leukemia (CML) and other indicated malignancies

Therapeutic class: Tyrosine kinase inhibitor (TKI)

Use in therapy: First-line and subsequent treatment for Ph+ CML and selected gastrointestinal stromal tumors (GIST)

Prescription status: Prescription-only anticancer medicine

Supplied by: Licensed manufacturers and authorised distributors

Storage: Store below 25 °C in a dry place, protected from moisture and light

Product Description

Veenat 100 mg and Veenat 400 mg tablets are
generic imatinib mesylate medicines used as part of targeted therapy for certain leukemias and solid tumors.
Imatinib is a well-known tyrosine kinase inhibitor that transformed the management of
Philadelphia chromosome–positive chronic myeloid leukemia (CML) and specific
gastrointestinal stromal tumors (GIST). This variable product listing combines both strengths so you can
buy Veenat online in either 100 mg (120 tablets) or 400 mg (30 tablets) form,
according to your oncologist’s prescription.

Veenat imatinib tablets are typically prescribed as long-term therapy. Many patients with chronic phase CML take
imatinib tablets daily for years to maintain remission and control leukemic cell counts.
Veenat 100 mg tablets are useful when flexible dosing or smaller adjustments are required, while
Veenat 400 mg tablets can provide a convenient standard-dose option. Because
Veenat is a generic imatinib product, it offers the same active ingredient as branded imatinib at more accessible USD pricing,
which is important when treatment continues over extended periods.

Each Veenat tablet contains imatinib mesylate corresponding to the stated strength of imatinib (100 mg or 400 mg).
The tablets are taken orally once or sometimes twice daily, depending on your prescribed total daily dose. When you
order Veenat online from Generic Meds Mart, you receive imatinib tablets supplied by licensed manufacturers and authorised distributors
that follow recognised Good Manufacturing Practice standards. The medicine is packed in discreet outer packaging to protect your privacy while preserving all original
product details on the blisters and cartons.

This Veenat 100 mg (120 tabs) / 400 mg (30 tabs) product is intended only for patients under the care of a haematologist or oncologist who has clearly
recommended imatinib therapy. Generic Meds Mart does not provide diagnosis or adjust treatment plans; this page is designed to support
informed discussions with your specialist about ongoing access to generic imatinib tablets.

Key Uses

Veenat imatinib tablets are typically used for the following indications under specialist supervision:

• Treatment of Philadelphia chromosome–positive chronic myeloid leukemia (CML) in chronic, accelerated or blast phase as directed
• Treatment of Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL) in selected cases
• Treatment of metastatic and/or unresectable gastrointestinal stromal tumors (GIST) expressing KIT (CD117)
• Treatment of certain other rare malignancies where imatinib is specifically recommended in the treatment protocol

Your specialist will determine the exact indication for Veenat 100 mg or Veenat 400 mg,
your total daily dose and how long imatinib therapy should continue.

How Imatinib Works in Chemotherapy

Imatinib is a targeted anticancer agent often grouped within modern chemotherapy and systemic treatments.
Veenat contains imatinib, a tyrosine kinase inhibitor (TKI) that blocks abnormal signalling from specific kinases such as BCR-ABL in CML
and KIT in many GIST tumors.

Veenat imatinib tablets selectively inhibit these overactive tyrosine kinases by blocking their ATP-binding site.
This interference disrupts signalling pathways that drive uncontrolled cell growth and survival. In
chronic myeloid leukemia, this can reduce leukemic cell counts and help achieve hematologic and cytogenetic responses.
In GIST, targeted inhibition of KIT can shrink or stabilise tumours that depend on this signalling pathway,
improving outcomes compared with non-targeted therapies.

Because imatinib acts as a targeted TKI rather than a traditional cytotoxic drug, its side effect profile differs from standard chemotherapy.
However, Veenat remains a potent anticancer treatment that requires regular monitoring and supervision by an experienced haematologist or oncologist.

Dosage & Administration

Veenat 100 mg and Veenat 400 mg imatinib tablets must always be taken exactly as prescribed by your specialist.
Daily dosing, timing and duration of therapy depend on your diagnosis, disease phase, response and tolerance.

• Take Veenat tablets by mouth with a large glass of water; some patients may be advised to take doses with food to reduce stomach discomfort.
• Swallow the tablets whole. Do not crush, split or chew Veenat tablets unless your doctor or pharmacist has given specific instructions.
• The total daily dose may be taken once daily or divided into two doses, depending on your prescription and tolerance.
• Do not change your dose, switch between Veenat 100 mg and Veenat 400 mg, or stop taking imatinib without clear instructions from your specialist.
• If you miss a dose, follow your doctor’s advice; do not double the next dose to make up for a missed tablet unless your oncologist has recommended it.

Your haematologist or oncologist will schedule regular blood tests and other assessments to monitor your response to
Veenat imatinib therapy and to adjust the dose if necessary.

Precautions

Before starting Veenat, tell your doctor about your complete medical history and all medicines, supplements or herbal products you use. Important considerations include:

• History of liver disease, kidney impairment or significant cardiac disease
• Pre-existing fluid retention, swelling, heart failure or shortness of breath
• Previous or current gastrointestinal bleeding or major stomach or bowel disease
• Use of other anticancer drugs, immunosuppressants or biologic therapies
• Use of strong CYP3A4 inhibitors or inducers, certain antibiotics, antifungals or antiepileptics that may interact with imatinib
• Use of paracetamol, anticoagulants or other medicines that may require careful monitoring when combined with Veenat imatinib tablets

Imatinib may not be suitable during pregnancy, and effective contraception is usually recommended during treatment and for a period afterwards, as advised by your doctor.
Breastfeeding is often discouraged while taking Veenat. Your specialist will decide what monitoring schedule is needed in your case.

Imatinib Side Effects

Common side effects

Many patients experience side effects when starting Veenat imatinib tablets, especially during the first months of treatment.
Common reactions may include:

• Mild to moderate nausea, vomiting or stomach discomfort
• Diarrhea or, in some cases, constipation
• Fluid retention with swelling of ankles, legs or around the eyes
• Muscle cramps, bone pain or joint discomfort
• Fatigue, weakness or general tiredness
• Mild skin rash or itching

These side effects are often manageable with supportive care or dose adjustments, but you should inform your oncology team about any persistent or troublesome symptoms.

Serious side effects

Some side effects of imatinib are less common but more serious and require urgent medical attention. Serious reactions may include:

• Marked fluid retention with sudden weight gain, shortness of breath or worsening swelling, which may indicate heart or lung complications
• Signs of severe liver problems, such as yellowing of the skin or eyes, dark urine, pale stools or intense upper abdominal pain
• Severe gastrointestinal symptoms, including severe abdominal pain, bloody stools or vomiting blood
• Significant changes in blood counts, with fever, frequent infections, easy bruising or unusual bleeding
• Severe skin reactions, widespread rash, blistering or mucosal involvement

If you experience any of these serious symptoms while taking Veenat 100 mg or Veenat 400 mg, seek immediate medical care and contact your specialist as soon as possible.

Storage

• Store Veenat tablets at room temperature, usually below 25 °C, in a dry place away from direct sunlight and excessive heat.
• Keep the tablets in their original blisters and cartons until use to protect them from moisture and light.
• Keep Veenat imatinib tablets out of the sight and reach of children and pets.
• Do not use the medicine after the expiry date printed on the packaging.

Ask your pharmacist or follow local regulations for safe disposal of unused or expired imatinib tablets.

Why Buy from Generic Meds Mart

Generic Meds Mart focuses on providing reliable access to essential oncology medicines such as
Veenat 100 mg  and Veenat 400 mg imatinib tablets at fair prices in USD.
We work only with licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a documented export track record.

When you buy Veenat online from Generic Meds Mart, you benefit from:

• Competitive pricing on generic imatinib tablets compared with many local pharmacies
• Discreet, plain packaging designed to protect your privacy during shipping
• Tracked international delivery options to many destinations
• Clear, structured product information to support discussions with your treating specialist
• Customer support available to assist with ordering, payment and shipping questions

Our goal is to help you maintain continuity of prescribed targeted therapy with transparent conditions and professional handling of each order.

Order Now

Veenat 100 mg and 400 mg imatinib tablets are prescription-only anticancer medicines and must be used strictly under the supervision of a haematologist or oncologist.
Before you order Veenat online, ensure that you have a valid prescription or written treatment plan specifying imatinib, the required daily dose and intended duration of therapy.

Select the prescribed strength — Veenat 100 mg (1 pack / 120 tablets) or Veenat 400 mg (1 pack / 30 tablets) —
choose the appropriate quantity, add Veenat to your cart and complete the secure checkout process. Your order will be processed, packed discreetly and shipped with tracking where available.

Generic Meds Mart does not provide diagnosis or personalised medical advice. All treatment decisions, dose changes and monitoring remain the responsibility of your oncology team.

Imat Imatinib – 100 mg, 400 mg (1 pack / 10 tabs) Tablets

At a Glance

Brand name: Imat

Generic name: Imatinib mesylate

Active ingredient: Imatinib

Strengths & packs: Imat 100 mg (1 pack / 10 tablets); Imat 400 mg (1 pack / 10 tablets)

Dosage form: Oral film-coated tablets

Main indication: Philadelphia chromosome–positive chronic myeloid leukemia (CML) and selected GIST

Therapeutic class: Tyrosine kinase inhibitor (TKI)

Use in therapy: First-line and subsequent targeted therapy for Ph+ CML and indicated solid tumors

Prescription status: Prescription-only anticancer medicine

Supplied by: Licensed manufacturers and authorised distributors

Storage: Store below 25 °C in a dry place, protected from moisture and light

Product Description

Imat 100 mg and Imat 400 mg tablets are
generic imatinib mesylate medicines used as part of targeted therapy for specific blood cancers and solid tumors.
Imatinib is a tyrosine kinase inhibitor (TKI) that has transformed the management of
Philadelphia chromosome–positive chronic myeloid leukemia (CML) and many gastrointestinal stromal tumors (GIST).
This variable product listing combines both strengths so you can buy Imat online in either
100 mg (1 pack / 10 tablets) or 400 mg (1 pack / 10 tablets) according to your specialist’s prescription.

Imat imatinib tablets are commonly prescribed as long-term daily therapy. In chronic phase CML,
imatinib tablets can help control leukemic cell counts, maintain remission and support long-term disease control.
Imat 100 mg tablets are useful when flexible dosing or smaller adjustments are needed, while
Imat 400 mg tablets offer a convenient standard-dose option. Because
Imat is a generic imatinib product, it contains the same active ingredient as branded imatinib but is often available at more accessible USD pricing,
which is important for extended treatment courses.

Each Imat tablet contains imatinib mesylate corresponding to the stated strength of imatinib (100 mg or 400 mg).
The tablets are taken orally with water, usually once daily or split into two doses, depending on the total daily dose and tolerability.
When you order Imat online from Generic Meds Mart, you receive imatinib tablets supplied by licensed manufacturers and authorised distributors
that follow recognised Good Manufacturing Practice standards. Original packaging retains full product details, while outer shipping materials are plain and discreet.

This Imat 100 mg (1 pack / 10 tabs) / 400 mg (1 pack / 10 tabs) product is intended only for patients under the care of a haematologist or oncologist
who has clearly recommended imatinib therapy. Generic Meds Mart does not provide diagnosis or change treatment plans;
this page is designed to support informed discussions with your specialist about access to generic imatinib tablets.

Key Uses

Imat imatinib tablets are generally used for the following indications under specialist supervision:

• Treatment of Philadelphia chromosome–positive chronic myeloid leukemia (CML) in chronic, accelerated or blast phase as directed
• Treatment of Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL) in selected cases
• Treatment of metastatic and/or unresectable gastrointestinal stromal tumors (GIST) expressing KIT (CD117)
• Treatment of other rare malignancies where imatinib is specifically recommended in recognised protocols

Your specialist will determine whether Imat 100 mg or Imat 400 mg is appropriate, how many tablets you should take per day and
how long imatinib therapy should continue.

How Imatinib Works in Chemotherapy

Imatinib is a targeted anticancer agent often grouped within modern systemic chemotherapy and targeted therapy regimens.
Imat contains imatinib, a tyrosine kinase inhibitor (TKI) that blocks abnormal signalling from specific tyrosine kinases such as BCR-ABL in CML
and KIT in many GIST tumours.

Imat imatinib tablets work by binding to these overactive tyrosine kinases and blocking their ATP-binding sites.
This disrupts signalling pathways that drive uncontrolled cancer cell growth and survival. In
chronic myeloid leukemia, this targeted inhibition can reduce leukemic cell counts and support long-term remission.
In GIST, inhibition of KIT can shrink or stabilise tumours that depend on this pathway.

Because imatinib acts as a targeted TKI rather than a traditional cytotoxic drug, its side effect profile differs from standard chemotherapy.
However, Imat is still a potent anticancer medicine and must be monitored carefully by an experienced haematologist or oncologist.

Dosage & Administration

Imat 100 mg and Imat 400 mg imatinib tablets must always be taken exactly as prescribed by your specialist.
Daily dosing, timing and duration of therapy depend on your diagnosis, disease phase, response and tolerance.

• Take Imat tablets by mouth with a large glass of water; some patients are advised to take doses with food to reduce stomach discomfort.
• Swallow the tablets whole. Do not crush, split or chew Imat tablets unless your doctor or pharmacist has given specific instructions.
• The total daily dose may be taken once daily or divided into two doses, depending on your prescription and tolerance.
• Do not change your dose, switch between Imat 100 mg and Imat 400 mg, or stop taking imatinib without clear instructions from your specialist.
• If you miss a dose, follow your doctor’s advice; do not double the next dose to make up for a missed tablet unless your oncologist has recommended it.

Your haematologist or oncologist will schedule regular blood tests and other assessments to monitor your response to
Imat imatinib therapy and adjust doses if needed.

Precautions

Before starting Imat, inform your doctor about your complete medical history and all medicines, supplements or herbal products you use. Important considerations include:

• History of liver disease, kidney impairment or significant cardiac disease
• Pre-existing fluid retention, swelling, heart failure or shortness of breath
• Previous or current gastrointestinal bleeding, ulcers or major stomach or bowel disease
• Use of other anticancer medicines, immunosuppressants or biologic therapies
• Use of strong CYP3A4 inhibitors or inducers, certain antibiotics, antifungals or antiepileptics that may interact with imatinib
• Use of paracetamol, anticoagulants or other medicines that may require careful monitoring with Imat imatinib tablets

Imatinib may not be suitable during pregnancy, and effective contraception is usually recommended during treatment and for a period afterwards, as advised by your doctor.
Breastfeeding is often discouraged while taking Imat. Your specialist will set an appropriate monitoring schedule in your case.

Imatinib Side Effects

Common side effects

Many patients experience side effects when starting Imat imatinib tablets, especially during the first months of treatment. Common reactions may include:

• Nausea, mild vomiting or stomach discomfort
• Diarrhea or, in some cases, constipation
• Fluid retention with swelling of ankles, legs or around the eyes
• Muscle cramps, bone pain or joint discomfort
• Fatigue, weakness or general tiredness
• Mild skin rash or itching

These side effects are often manageable with supportive care or dose adjustments, but you should report persistent or troublesome symptoms to your oncology team.

Serious side effects

Some side effects of imatinib are less common but more serious and require urgent medical attention. Serious reactions may include:

• Marked fluid retention with sudden weight gain, worsening shortness of breath or pronounced leg swelling
• Signs of severe liver problems, such as yellowing of the skin or eyes, dark urine, pale stools or intense upper abdominal pain
• Severe abdominal pain, bloody stools or vomiting blood, which may indicate serious gastrointestinal issues
• Significant changes in blood counts, with fever, frequent infections, unusual bruising or prolonged bleeding
• Severe skin reactions, widespread rash, blistering or involvement of the mouth or eyes

If you experience any of these serious symptoms while taking Imat 100 mg or Imat 400 mg, seek immediate medical care and contact your specialist as soon as possible.

Storage

• Store Imat tablets at room temperature, usually below 25 °C, in a dry place away from direct sunlight and excess heat.
• Keep the tablets in their original blisters and cartons until use to protect them from moisture and light.
• Keep Imat imatinib tablets out of the sight and reach of children and pets.
• Do not use the medicine after the expiry date printed on the packaging.

Ask your pharmacist or follow local regulations for safe disposal of unused or expired imatinib tablets.

Why Buy from Generic Meds Mart

Generic Meds Mart focuses on providing reliable access to essential oncology medicines such as
Imat 100 mg and Imat 400 mg imatinib tablets at fair prices in USD.
We work only with licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a documented export track record.

When you buy Imat online from Generic Meds Mart, you benefit from:

• Competitive pricing on generic imatinib tablets compared with many local pharmacies
• Discreet, plain packaging designed to protect your privacy during shipping
• Tracked international delivery options to many destinations
• Clear, structured product information to support discussions with your haematologist or oncologist
• Customer support available to assist with ordering, payment and shipping questions

Our goal is to help you maintain continuity of prescribed targeted therapy with transparent conditions and professional handling of each order.

Order Now

Imat 100 mg and 400 mg imatinib tablets are prescription-only anticancer medicines and must be used strictly under the supervision of a haematologist or oncologist.
Before you order Imat online, ensure that you have a valid prescription or written treatment plan specifying imatinib, the required daily dose and intended duration of therapy.

Select the prescribed strength — Imat 100 mg (1 pack / 10 tablets) or Imat 400 mg (1 pack / 10 tablets) —
choose the appropriate quantity, add Imat to your cart and complete the secure checkout process. Your order will be processed, packed discreetly and shipped with tracking where available.

Generic Meds Mart does not provide diagnosis or personalised medical advice. All treatment decisions, dose changes and monitoring remain the responsibility of your oncology team.

Dasatrue Dasatinib Tablets 50 mg / 70 mg (1 pack / 60 tabs)

At a Glance

Generic Name: Dasatinib

Brand Name: Dasatrue

Strength & Pack Size: 50 mg or 70 mg per tablet; 1 pack / 60 tablets

Dosage Form & Route: Oral tablet, swallowed whole with water

Therapeutic Class: Tyrosine kinase inhibitor (TKI), BCR-ABL inhibitor (targeted anticancer therapy)

Primary Indication: Chronic myeloid leukemia (CML) and Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL) where dasatinib is appropriate

Typical Use in Therapy: Used within a hematology–oncology plan with response monitoring and blood tests

Prescription Status: Prescription-only medicine

Storage: Store in original packaging as directed; protect from moisture and keep out of reach of children

Product Description

Dasatrue contains dasatinib, a targeted oral tyrosine kinase inhibitor used in CML and Ph+ ALL when a qualified hematology–oncology specialist determines it is appropriate. Dasatrue is supplied as dasatinib tablets in two strengths (50 mg and 70 mg), with this listing covering 1 pack / 60 tablets per selected strength. If you plan to buy Dasatrue online, match the strength to your prescription and monitoring plan rather than choosing based only on price or availability.

In Philadelphia chromosome–positive leukemias, the abnormal BCR-ABL signal is a key driver of malignant cell growth. Dasatinib targets this pathway as a second-generation TKI, and treatment decisions are individualized based on disease phase, prior therapies, response goals, tolerability, and interaction risks. Patients are usually followed with scheduled blood counts and response assessments, and dose changes are made only by the treating team. Dasatrue is prescription-only and should not be started, stopped, or adjusted without specialist supervision.

Generic Meds Mart supplies Dasatrue dasatinib tablets in original manufacturer packaging sourced through licensed channels. Packs typically show the product name, selected strength, active ingredient, batch number, and expiry date to support pharmacy verification on receipt. Orders are shipped in discreet outer packaging, and delivery wording is kept practical (global delivery / international delivery / worldwide delivery) so patients and clinics can coordinate refills with planned monitoring.

Key Uses

Dasatrue (dasatinib) is used for CML and Ph+ ALL when BCR-ABL tyrosine kinase inhibition is clinically appropriate. These conditions require specialist-led monitoring because both efficacy and safety depend on individualized dosing, response checks, and early recognition of complications such as cytopenias or fluid-related effects. Your hematology team defines the treatment goals, what response milestones are expected, and what follow-up schedule is required.

Common Searches and Treatment Contexts for Dasatinib

• Generic Sprycel (Dasatinib): Dasatrue is a therapeutically equivalent generic version of the brand-name drug Sprycel, containing the same active ingredient (dasatinib 50 mg or dasatinib 70 mg) for the treatment of CML and Ph+ ALL.
• BCR-ABL TKI for CML: Dasatinib is a potent second-generation tyrosine kinase inhibitor that targets the BCR-ABL protein, a key driver in Philadelphia chromosome–positive leukemias.
• Dasatinib 50 mg Tablets / Dasatinib 70 mg Tablets: These strengths are used within individualized regimens prescribed by a hematology specialist based on response and tolerability.
• Buy Dasatinib Online: Patients with a confirmed prescription and monitoring plan may seek reliable access to original-packaging dasatinib to maintain therapy continuity.

How Dasatinib Works in Chemotherapy

Dasatinib inhibits tyrosine kinases involved in leukemia cell signaling, including BCR-ABL. In Ph+ disease, BCR-ABL signaling promotes uncontrolled growth and survival of malignant cells. By blocking these signals, dasatinib reduces downstream pathways that cancer cells rely on, supporting disease control when taken consistently as prescribed within a specialist-managed plan.

Because dasatinib is targeted therapy rather than classic cytotoxic chemotherapy, the side-effect profile differs, but monitoring remains essential. Your specialist may monitor blood counts, infection signs, bleeding risk, and symptoms suggestive of fluid accumulation. Treatment decisions should always be made with your hematology team, especially if you take other medicines that may interact.

Dosage & Administration

Dasatrue tablets must be taken exactly as prescribed by your hematology–oncology specialist. Dasatinib dosage is individualized and may be adjusted based on disease phase, treatment response, tolerability, and interacting medicines. Swallow tablets whole with water and follow the schedule provided by your clinic. If you miss a dose, follow your clinic’s instructions rather than taking extra tablets to compensate.

Interactions can be clinically important with dasatinib. Always share a complete list of prescription medicines, over-the-counter products, and supplements with your specialist and pharmacist before starting therapy and before adding anything new. Never stop or change dosing without medical advice, because continuity and monitoring are core parts of safe targeted treatment.

Precautions

Dasatinib can affect blood counts, increasing infection and bleeding risk. Seek medical advice urgently for fever, chills, unusual bruising, prolonged bleeding, black stools, or severe fatigue. Fluid-related effects such as pleural effusion may occur in some patients and can present as cough, chest discomfort, or shortness of breath; new or worsening breathing symptoms should be assessed promptly.

Your specialist will also consider other risk factors and may recommend specific monitoring based on your situation. Pregnancy should be avoided during anticancer therapy, and contraception planning should be discussed with a qualified healthcare professional.

Dasatinib Side Effects

Common side effects

Common dasatinib side effects may include diarrhea, nausea, fatigue, headache, muscle or joint aches, mild rash, and laboratory changes in blood counts. Many effects can be managed within a specialist-led plan, but persistent or worsening symptoms should be discussed with your care team rather than managed by changing the dose independently.

Serious side effects

Serious side effects require urgent medical attention and may include major bleeding, severe or recurrent infections, significant reductions in blood counts, or clinically important fluid accumulation around the lungs. If you develop high fever, heavy bleeding, black stools, chest pain, fainting, or rapidly worsening shortness of breath, seek urgent care and tell clinicians you are taking dasatinib.

Storage

Store Dasatrue in the original packaging as directed on the label, protect from moisture and excessive heat, and keep out of reach of children. Do not use after the expiry date on the carton or blister/bottle. Follow any clinic-specific handling instructions provided for oncology medicines.

Why Buy from Generic Meds Mart

Generic Meds Mart supports access and logistics for specialty medicines such as Dasatrue dasatinib tablets. Products are supplied in original packaging from licensed channels with batch and expiry information for verification. Pricing is displayed in USD, checkout is secure, and shipments are packed in discreet outer cartons to protect privacy.

For patients managing CML or Ph+ ALL within a monitoring plan, reliable access can support therapy continuity. Global delivery options and tracking can help align refills with blood tests and specialist visits. Generic Meds Mart does not replace your treating doctor, and all clinical decisions about dasatinib therapy, including monitoring and side-effect management, must be made by qualified healthcare professionals.

Order Now

Before you order Dasatrue, you should have a confirmed diagnosis of CML or Ph+ ALL and a treatment plan agreed with your hematology–oncology specialist. Your care team will explain which monitoring tests are required and how often, and they will review interaction risks with your current medicines. Once your plan is confirmed, select the correct strength (Dasatrue 50 mg or Dasatrue 70 mg), add 1 pack / 60 tablets to your cart, and complete checkout in USD.

Do not start therapy on your own, and do not stop or change dosing without medical guidance. If you develop concerning symptoms such as heavy bleeding, high fever, chest pain, or worsening shortness of breath, seek urgent medical care and inform clinicians that you are taking dasatinib.

FAQ about Dasatrue (Dasatinib)

Q1: What is Dasatrue used for?
Dasatrue contains dasatinib, a targeted tyrosine kinase inhibitor used in CML and Ph+ ALL when prescribed by a hematology–oncology specialist as part of a complete treatment plan.

Q2: Is Dasatrue a chemotherapy medicine or targeted therapy?
Dasatrue (dasatinib) is targeted therapy that inhibits BCR-ABL and related kinases in Philadelphia chromosome–positive disease. It still requires specialist supervision and monitoring.

Q3: How should I take Dasatrue tablets?
Take Dasatrue exactly as prescribed. Swallow tablets whole with water and follow your specialist’s schedule and monitoring instructions.

Q4: What should I know about dasatinib dosage and missed doses?
Dasatinib dosage is individualized by your specialist. If you miss a dose, follow your clinic’s instructions and do not take extra tablets unless your specialist tells you to.

Q5: What are common dasatinib side effects to monitor?
Common dasatinib side effects can include diarrhea, fatigue, rash, and changes in blood counts. Report persistent or severe symptoms so your care team can advise safely.

Q6: Is Dasatrue 50 mg or 70 mg the same as Sprycel (Generic Sprycel)?
Dasatrue is Generic Sprycel — it contains the same active ingredient (dasatinib) as Sprycel. It’s used for the same indication at the same strength, while differences may be in manufacturer, inactive ingredients (excipients), tablet appearance, and packaging. If you’re switching between products, confirm the substitution with a qualified healthcare professional.

Spnib 100 mg Dasatinib Tablets (1 bottle / 30 tabs)

At a Glance

Generic Name: Dasatinib

Brand Name: Spnib 100 mg

Strength & Pack Size: 100 mg tablets, 1 bottle / 30 tablets

Dosage Form & Route: Oral film-coated tablets for swallowing whole with water

Therapeutic Class: Second-generation BCR-ABL tyrosine kinase inhibitor and SRC family kinase inhibitor

Primary Indications: Philadelphia chromosome–positive chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic leukemia (ALL), according to local label

Typical Use in Therapy: Used as first- or subsequent-line TKI option in Ph+ CML or Ph+ ALL under specialist protocols

Mode of Action: Inhibits BCR-ABL and other kinases to block abnormal signalling and leukemic cell proliferation

Key Benefits: Active in many patients resistant or intolerant to imatinib, with rapid and deep molecular responses in appropriately selected cases

Precautions: Myelosuppression, bleeding, fluid retention, pulmonary arterial hypertension and QT prolongation require close monitoring

Storage: Store below 25 °C in the original container, tightly closed and protected from moisture

Product Description

Spnib 100 mg contains dasatinib, an oral second-generation tyrosine kinase inhibitor used in the treatment of Philadelphia chromosome–positive leukemias. It is typically prescribed for Ph+ chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic leukemia (ALL) in adults when a potent BCR-ABL inhibitor is needed, including situations where imatinib has failed due to resistance or intolerance, or where local protocols support dasatinib in earlier lines of therapy.

Each bottle of Spnib 100 mg supplied by Generic Meds Mart contains 30 film-coated dasatinib tablets. The 100 mg strength is commonly used in adult regimens, although the exact dose and schedule are always determined by a hematologist or oncologist based on disease phase, prior treatment, concomitant medicines and the patient’s overall health. Spnib 100 mg dasatinib tablets are taken by mouth, usually once daily, and are intended for long-term use as part of a continuous tyrosine kinase inhibitor strategy for Ph+ CML or Ph+ ALL where clinically appropriate.

Generic Meds Mart works only with licensed manufacturers and authorised distributors for oncology TKIs like Spnib 100 mg. Bottles are supplied in original, sealed packaging so that treating centres can verify brand, strength, batch number and expiry before dispensing. Outer shipping cartons are neutral, without visible references to leukemia or dasatinib, helping to protect patient privacy during international delivery. Prices are displayed in USD to make long-term therapy planning more transparent for patients and clinics.

Key Uses

Spnib 100 mg dasatinib tablets are used for guideline-based indications in Philadelphia chromosome–positive leukemias, according to local product information and specialist recommendations. In clinical practice, this typically includes:

Spnib 100 mg as a second-generation BCR-ABL inhibitor in adults with Ph+ CML, including chronic, accelerated or blast phase disease where dasatinib is considered appropriate by the treating team.

Spnib 100 mg in adults with Ph+ ALL when a potent oral TKI is required in induction, consolidation or maintenance phases alongside multi-agent chemotherapy or other targeted regimens, based on protocol.

Depending on region and label, dasatinib may be used either after imatinib failure or intolerance, or as a first-line option in selected patients. The decision to use Spnib 100 mg, and its position relative to other TKIs such as imatinib or nilotinib, must always be made by an experienced hematologist working within evidence-based guidelines.

How Dasatinib Works in Chemotherapy

Dasatinib, the active ingredient in Spnib 100 mg, is a potent inhibitor of the BCR-ABL tyrosine kinase, the abnormal fusion protein generated by the Philadelphia chromosome translocation t(9;22). This fusion kinase drives uncontrolled proliferation and survival of leukemic cells in Ph+ CML and Ph+ ALL.

By binding to and inhibiting BCR-ABL, dasatinib blocks downstream signalling pathways that support leukemic cell division and resistance to apoptosis. Dasatinib also inhibits other kinases, including members of the SRC family, which may contribute to its activity in leukemic cells. Compared with first-generation TKIs, dasatinib has broader binding characteristics and can retain activity against many imatinib-resistant BCR-ABL mutations, although some mutations remain problematic.

In clinical use, effective inhibition of BCR-ABL by Spnib 100 mg dasatinib tablets can lead to rapid reductions in leukocyte counts, improved bone marrow morphology and achievement of cytogenetic and molecular responses. Achieving and maintaining deep molecular responses is associated with better long-term outcomes in Ph+ CML and Ph+ ALL when managed according to specialist protocols.

Dosage & Administration

Spnib 100 mg must be prescribed and monitored by a hematologist or oncologist experienced in managing Ph+ leukemias. The usual adult dose and schedule are defined in the official product information and may vary according to indication, disease phase, prior therapies and local practice. Tablets are swallowed whole with water and should not be crushed or chewed.

Dasatinib can be taken with or without food, but patients should follow the exact instructions given by their treatment centre. Certain medicines, including proton pump inhibitors and strong CYP3A4 inhibitors or inducers, can affect dasatinib exposure and may need to be avoided or adjusted. Regular blood counts, liver function tests and clinical assessments are required to monitor response and toxicity. Dose interruptions, reductions or switches to an alternative TKI may be necessary in cases of significant myelosuppression, fluid retention, pulmonary events or other adverse effects. Patients should never change their Spnib 100 mg dose without specialist advice.

Precautions

Before starting Spnib 100 mg dasatinib tablets, the treatment team will review the patient’s medical history, ECG, cardiovascular status, liver and kidney function, concomitant medicines and bleeding risk. Dasatinib can cause myelosuppression, including neutropenia, thrombocytopenia and anemia, so frequent full blood count monitoring is essential, particularly in the first months of therapy.

Important precautions described in dasatinib prescribing information include risks of serious bleeding, fluid retention (such as pleural effusion and pericardial effusion), pulmonary arterial hypertension, QT interval prolongation and hepatotoxicity. Caution is required in patients with prior heart disease, uncontrolled hypertension, lung disease, liver impairment or those taking other QT-prolonging drugs. Women who are pregnant or may become pregnant should not handle dasatinib tablets without protection, and effective contraception is recommended for patients of reproductive potential.

Dasatinib Side Effects

Common side effects

Common dasatinib side effects in patients taking Spnib 100 mg include myelosuppression with low white cells, low platelets or anemia; headache; fatigue; nausea; vomiting; diarrhoea; abdominal discomfort; rash; musculoskeletal pain; mild fluid retention such as ankle swelling; and mild elevations in liver enzymes. Some patients experience cough or shortness of breath, which may be related to fluid around the lungs and must be assessed by the treating team.

These effects are often manageable with temporary treatment interruption, dose reduction, supportive therapy such as transfusions or growth factors and careful monitoring. Patients should attend all scheduled blood tests and clinic visits so that emerging issues can be detected early.

Serious side effects

Serious dasatinib adverse effects require urgent medical attention. These may include severe thrombocytopenia or neutropenia with increased risk of bleeding or infection; major haemorrhage; significant pleural or pericardial effusion; signs of pulmonary arterial hypertension such as progressive shortness of breath and fatigue; marked fluid overload; severe liver injury with jaundice; and serious cardiac events or marked QT prolongation.

Patients should contact emergency services or their treating centre immediately if they experience chest pain, severe shortness of breath, sudden swelling, black or bloody stools, coughing up blood, high fever, uncontrolled bleeding, confusion, severe dizziness or fainting. The treating team may need to interrupt Spnib 100 mg, adjust the dose or switch to an alternative therapy depending on the severity and type of adverse event.

Storage

Spnib 100 mg dasatinib tablets should be stored in the original, tightly closed bottle below 25 °C, protected from moisture and heat. The bottle should be kept out of the sight and reach of children and should not be stored in very humid environments such as bathrooms. Tablets must not be used after the expiry date shown on the label and carton. Unused or expired tablets should be returned to a pharmacy or disposed of in accordance with local oncology waste guidelines, not placed in household rubbish or wastewater.

Why Buy from Generic Meds Mart

Generic Meds Mart is focused on structured access to specialist oral oncology medicines such as Spnib 100 mg dasatinib tablets. We source only from licensed manufacturers and authorised distributors who comply with Good Manufacturing Practice and maintain traceable batch records. Each bottle of Spnib 100 mg is supplied in sealed, original packaging so pharmacists and clinicians can verify brand name, strength, batch number and expiry before dispensing to patients.

Orders placed through Generic Meds Mart are billed in USD, simplifying cost planning for long-term TKI therapy. Shipments are packed in neutral outer cartons with no explicit mention of leukemia, dasatinib or Spnib 100 mg, and where available, tracking information is provided so that patients and clinics can coordinate refills before existing supplies run out. Our support team can help with ordering and logistics questions, while all decisions about whether to use a specific tyrosine kinase inhibitor remain exclusively with your hematology or oncology team.

Order Now

Spnib 100 mg dasatinib tablets are a potent, targeted therapy for Philadelphia chromosome–positive leukemias and must not be started without a detailed plan from an experienced specialist. Before you buy Spnib 100 mg online from Generic Meds Mart, ensure that your diagnosis, BCR-ABL status, prior TKI exposure and overall treatment goals have been fully discussed with your hematologist. You should have clear instructions about your daily dose, timing, monitoring schedule and what to do if doses are missed or side effects occur.

Once your plan is in place, your team can calculate how many bottles of Spnib 100 mg (1 bottle / 30 tabs) are needed for the initial treatment period. You can then select the appropriate quantity on Generic Meds Mart, add it to your cart and complete secure checkout in USD. Your medicine will be shipped in discreet packaging with full product labelling. You should never change, pause or stop dasatinib therapy on your own; any new or severe symptoms must be discussed promptly with your specialist team, and emergency services should be contacted when serious warning signs appear.

FAQ about Spnib (Dasatinib)

Q1: What is Spnib 100 mg used for?
Spnib 100 mg contains dasatinib, a second-generation BCR-ABL tyrosine kinase inhibitor used under specialist supervision for Philadelphia chromosome–positive chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic leukemia (ALL), according to local approvals and guidelines.

Q2: How should I take Spnib 100 mg tablets?
Spnib 100 mg dasatinib tablets are usually taken once daily, swallowed whole with water. You should follow the exact dose and timing given by your hematologist and avoid crushing or chewing the tablets. If you miss a dose, follow the instructions in your product leaflet or contact your clinic rather than doubling up the next day.

Q3: Will I need regular blood tests while on dasatinib?
Yes. Dasatinib can cause myelosuppression and other laboratory changes, so regular full blood counts and chemistry tests are essential, especially early in treatment. Your team will use these results to adjust your dose, pause therapy or provide supportive care if necessary.

Q4: Can Spnib 100 mg interact with other medicines?
Dasatinib is metabolised by CYP3A4 and can interact with many medicines, including certain antifungals, antibiotics, antivirals, anticonvulsants and stomach acid–reducing drugs. You should provide a full list of all prescription, over-the-counter and herbal products to your specialist, and never start or stop any medicine without checking for potential interactions.

Q5: How long will I need to stay on Spnib 100 mg?
Treatment duration with Spnib 100 mg dasatinib tablets is highly individual. Many patients remain on therapy for years to maintain deep molecular responses, while others may switch TKIs or change strategy if responses are suboptimal or side effects are problematic. Your hematologist will review your response milestones and overall health to decide whether to continue, adjust or change treatment over time.

Invista 100 mg Dasatinib Tablets (1 pack / 10 tabs)

At a Glance

Generic Name: Dasatinib

Brand Name: Invista

Strength & Pack Size: 100 mg per tablet; 1 pack / 10 tablets

Dosage Form & Route: Oral tablet, swallowed whole with water

Therapeutic Class: Tyrosine kinase inhibitor (BCR-ABL/Src family), targeted anticancer therapy

Primary Indication: Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)

Usual Adult Dose: Often 100 mg once daily in adult CML regimens, but dose and schedule are defined by your specialist

Prescription Status: Prescription-only medicine

Storage: Store below 25-30 °C in the original blister pack, protect from moisture and keep out of reach of children

Product Description

Invista 100 mg contains dasatinib, an oral targeted medicine used in certain blood cancers driven by abnormal tyrosine kinase signaling. It is prescribed for Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) and for Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in treatment settings where a specialist decides that dasatinib is appropriate. This pack provides 100 mg tablets supplied as 1 pack / 10 tablets, intended to support a planned treatment schedule and routine monitoring as directed by your hematology-oncology team.

Dasatinib is a prescription-only anticancer medicine and is not suitable for self-selection. In CML and Ph+ ALL care, your hematology-oncology team considers disease phase, prior therapies, comorbidities, infection history, bleeding risk, and potential drug interactions before choosing a regimen. Some patients receive dasatinib as first-line therapy, while others receive it after resistance or intolerance to another tyrosine kinase inhibitor, and the goals of treatment are always individualized.

Generic Meds Mart supplies Invista 100 mg dasatinib tablets in original manufacturer packaging sourced through licensed channels. The carton and blister typically show the brand name, strength, active ingredient, batch number, and expiry date so your clinic or pharmacy can verify product identity on receipt. Orders are processed with secure checkout in USD and shipped in discreet outer packaging to support privacy, with international delivery options designed to help patients coordinate refills with specialist monitoring. If you are comparing options, ask your clinic to confirm the correct strength and pack size before ordering and avoid making decisions based only on dasatinib price.

Key Uses

Invista 100 mg dasatinib is used to treat Philadelphia chromosome-positive chronic myeloid leukemia, including chronic phase and other phases when a specialist recommends a dasatinib-based approach. CML is a myeloproliferative cancer associated with the BCR-ABL fusion protein, and long-term disease control often depends on consistent kinase inhibition together with scheduled laboratory monitoring.

Dasatinib is also used in Philadelphia chromosome-positive acute lymphoblastic leukemia, usually as part of a specialist-led protocol that may include additional medicines. The exact indication, combination strategy, and duration are individualized, and your team will explain how response is assessed, how often blood tests are required, and which symptoms should prompt urgent contact.

How Dasatinib Works in Chemotherapy

Dasatinib inhibits multiple tyrosine kinases, including BCR-ABL and members of the Src family, which are involved in signaling pathways that help malignant cells survive and proliferate. In Philadelphia chromosome-positive disease, BCR-ABL acts like a continuously active switch that drives abnormal cell growth. By blocking this signaling, dasatinib can reduce the growth advantage of leukemic cells and help bring blood counts and disease markers under control over time when therapy is taken consistently as prescribed.

Because dasatinib is a targeted inhibitor rather than a classic DNA-damaging chemotherapy, its effects and risks differ from many older regimens. Treatment still requires careful monitoring, and side effects can involve blood counts, fluid retention, bleeding tendency, or infections depending on individual risk factors and concomitant medicines. Your specialist balances expected benefit with safety and may adjust therapy based on laboratory trends, symptoms, and known interactions.

Dosage & Administration

Invista 100 mg tablets are taken by mouth exactly as prescribed by your hematology-oncology specialist. In adult CML regimens, dasatinib is often taken once daily, but the appropriate dose can differ depending on diagnosis, disease phase, response, tolerability, and other medicines. Swallow the tablet whole with water and take it at about the same time each day unless your clinic instructs otherwise.

Drug interactions can be clinically important with dasatinib. Certain strong CYP3A inhibitors or inducers may change drug exposure, and some acid-reducing medicines may need careful timing or alternatives because they can affect absorption. Always share a complete list of prescription medicines, over-the-counter products, and supplements with your specialist and pharmacist. If a dose is missed, follow your clinic’s instructions and do not take extra tablets to compensate unless your care team explicitly instructs you to do so.

Precautions

Dasatinib can cause myelosuppression, meaning reductions in white blood cells, red blood cells, and platelets. Regular blood tests are required, and dose interruptions or adjustments may be needed if cytopenias become significant. Contact your clinic urgently if you develop fever, chills, persistent sore throat, unusual bruising or bleeding, or severe fatigue, as these can signal infection, bleeding, or other complications that need prompt assessment.

Fluid retention is an important risk with dasatinib and may present as swelling, rapid weight gain, or pleural effusion with new or worsening cough or breathing difficulty. Some patients may experience pulmonary arterial hypertension, which requires specialist evaluation. Dasatinib may also increase bleeding risk, especially when combined with anticoagulants or antiplatelet medicines. Pregnancy should be avoided during treatment, and contraception planning should be discussed with your specialist before starting therapy.

Dasatinib Side Effects

Common side effects

Common dasatinib side effects may include headache, diarrhea, nausea, fatigue, muscle or joint aches, skin rash, and mild bruising. Blood tests may show anemia, neutropenia, or thrombocytopenia that require monitoring and, in some cases, supportive care or dose modification. Many effects are manageable when identified early, so report persistent or worsening symptoms rather than adjusting treatment on your own.

Serious side effects

Serious side effects require urgent medical attention and can include severe infection, heavy or unusual bleeding, marked shortness of breath, chest pain, or signs of significant fluid retention such as pleural effusion. Severe drops in blood counts, severe skin reactions, and clinically important liver test abnormalities can also occur. If you experience high fever, severe breathing difficulty, fainting, coughing up blood, or rapidly worsening symptoms, seek emergency care and inform clinicians that you are taking dasatinib.

Storage

Store Invista 100 mg below 25-30 °C, protected from moisture and direct heat, and keep the tablets in the original blister pack until use. Keep all medicines out of reach of children. Do not use the tablets after the expiry date printed on the carton or blister, and follow local guidance or your pharmacist’s advice for safe disposal of unused tablets.

Why Buy from Generic Meds Mart

Generic Meds Mart supports access and logistics for specialty medicines such as Invista 100 mg dasatinib tablets. Products are supplied in original packaging from licensed channels with batch and expiry information to support verification by pharmacies and clinics, and discreet packaging helps protect privacy during delivery.

Prices are shown in USD to support planning, orders are processed with secure checkout, and worldwide delivery options can help patients coordinate refills with monitoring schedules and specialist visits. Generic Meds Mart does not replace your treating doctor; decisions about whether dasatinib is appropriate, how long to use it, and how to manage side effects must be made by qualified healthcare professionals.

Order Now

Before you buy Invista 100 mg online from Generic Meds Mart, you should have a confirmed diagnosis of Ph+ CML or Ph+ ALL and a treatment plan agreed with your hematology-oncology specialist. Your care team will advise which monitoring tests are needed and how often, and they will review interaction risks with your current medicines so your dasatinib dosage and schedule are clear.

Once your plan is confirmed, select Invista 100 mg (1 pack / 10 tabs), add it to your cart, and complete secure checkout in USD. Do not start therapy on your own, and do not stop or change dosing without medical guidance. If you develop concerning symptoms such as heavy bleeding, fever, signs of serious infection, chest pain, or persistent breathing problems, seek urgent medical care and inform clinicians that you are taking dasatinib.

FAQ about Invista (Dasatinib)

Q1: What is Invista 100 mg used for?

Invista 100 mg contains dasatinib, a tyrosine kinase inhibitor used in Philadelphia chromosome-positive chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia when prescribed by a hematology-oncology specialist.

Q2: How should I take Invista 100 mg tablets?

Invista tablets are taken by mouth on a schedule defined by your specialist. Swallow the tablet whole with water and take it consistently as directed, with or without food depending on your clinic’s instructions.

Q3: Can Invista interact with other medicines?

Yes. Some medicines can change dasatinib exposure, and acid-reducing products may require careful timing or alternatives. Share a full list of medicines and supplements with your specialist so safe timing can be planned.

Q4: What should I do if I miss a dose?

If you miss a dose, follow your clinic’s instructions and do not take extra tablets to compensate unless your specialist tells you to. If you are unsure, contact your prescribing team for guidance.

Q5: What monitoring is usually needed during treatment?

Monitoring commonly includes blood counts and clinical checks for infection, bleeding symptoms, and breathing issues related to fluid retention, with frequency defined by your specialist based on your treatment plan.

Imatib Imatinib – 100 mg (1 pack / 10 tablets)

At a Glance

Brand name: Imatib

Generic name: Imatinib mesylate

Active ingredient: Imatinib

Strength & pack size: Imatib 100 mg (1 pack / 10 tablets)

Dosage form: Oral film-coated tablets

Main indication: Philadelphia chromosome–positive chronic myeloid leukemia (CML) and selected gastrointestinal stromal tumors (GIST)

Therapeutic class: Tyrosine kinase inhibitor (TKI)

Use in therapy: Targeted systemic treatment for Ph+ CML and indicated solid tumors

Prescription status: Prescription-only anticancer medicine

Supplied by: Licensed manufacturers and authorised distributors

Storage: Store below 25 °C in a dry place, protected from moisture and light

Product Description

Imatib 100 mg tablets are a generic imatinib mesylate medicine used in the treatment of specific blood cancers and solid tumors.
Imatinib is a well-known tyrosine kinase inhibitor (TKI) that has transformed outcomes for patients with
Philadelphia chromosome–positive chronic myeloid leukemia (CML) and certain gastrointestinal stromal tumors (GIST).
Imatib 100 mg (1 pack / 10 tablets) offers a compact pack size that may be used as an initial supply, a short bridging course or as continuation therapy,
always according to your specialist’s prescription.

Each Imatib tablet contains 100 mg of imatinib, taken by mouth, usually once or twice daily depending on the required total daily dose.
The 100 mg strength provides flexibility for dose titration and individualised treatment regimens. Because
Imatib is a generic imatinib product, it contains the same active ingredient as branded imatinib while offering a more accessible price in USD,
which can be important for patients who need long-term imatinib therapy.

When you buy Imatib 100 mg online from Generic Meds Mart, you receive imatinib tablets supplied by licensed manufacturers and authorised distributors
that follow recognised GMP standards. The medicine is shipped in plain, discreet outer packaging, while original blisters and cartons maintain full details such as strength, batch number and expiry date.

This Imatib 100 mg (1 pack / 10 tablets) product is intended only for patients already under the care of a haematologist or oncologist who has recommended
imatinib tablets as part of a treatment plan. Generic Meds Mart does not diagnose conditions or change treatment protocols;
the information on this page is designed to support informed discussions with your specialist about access to generic imatinib.

Key Uses

Imatib 100 mg imatinib tablets are typically used for the following indications under specialist supervision:

• Treatment of Philadelphia chromosome–positive chronic myeloid leukemia (CML) in chronic, accelerated or blast phase as directed
• Treatment of Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL) in selected patients
• Treatment of metastatic and/or unresectable gastrointestinal stromal tumors (GIST) expressing KIT (CD117) or other relevant targets
• Treatment of other rare malignancies where imatinib is specifically recommended in recognised oncology guidelines

Your specialist will determine how Imatib 100 mg fits into your therapy, what total daily dose you need and how long
imatinib treatment should continue.

How Imatinib Works in Chemotherapy

Imatinib is a targeted anticancer agent often grouped within modern systemic chemotherapy and targeted therapy regimens.
Imatib 100 mg contains imatinib, a tyrosine kinase inhibitor (TKI) that blocks abnormal signalling from specific tyrosine kinases such as BCR-ABL in CML
and KIT in many GIST tumours.

Imatib imatinib tablets work by binding to these overactive kinases and blocking their ATP-binding sites.
This disrupts the signalling pathways that drive uncontrolled cancer cell growth and survival. In
chronic myeloid leukemia, this targeted inhibition can reduce leukemic cell counts and support long-term disease control.
In GIST, inhibition of KIT may shrink or stabilise tumours that depend on this pathway.

Because imatinib acts as a targeted TKI rather than a traditional cytotoxic drug, its side effect profile differs from standard chemotherapy.
However, Imatib 100 mg is still a potent anticancer medicine that must be monitored carefully by an experienced haematologist or oncologist.

Dosage & Administration

Imatib 100 mg imatinib tablets must always be taken exactly as prescribed by your specialist.
Daily dosing, timing and duration of therapy depend on your diagnosis, disease phase, response and tolerance.

• Take Imatib tablets by mouth with a large glass of water; many patients are advised to take doses with food to reduce stomach discomfort.
• Swallow the tablets whole. Do not crush, split or chew Imatib 100 mg tablets unless your doctor or pharmacist has given specific instructions.
• The total daily dose may be taken once daily or divided into two doses, depending on your prescription and how well you tolerate treatment.
• Do not change your dose or stop taking Imatib without clear instructions from your haematologist or oncologist.
• If you miss a dose, follow your doctor’s advice; do not double the next dose to compensate unless your specialist has recommended it.

Your oncology team will schedule regular blood tests and other assessments to monitor your response to
Imatib imatinib therapy and to guide any necessary dose adjustments.

Precautions

Before starting Imatib 100 mg, inform your doctor about your full medical history and all medicines, supplements or herbal products you use. Important considerations include:

• History of liver disease, kidney impairment or significant cardiac disease
• Pre-existing fluid retention, swelling, heart failure or shortness of breath
• Previous or current gastrointestinal bleeding, ulcers or serious stomach or bowel conditions
• Use of other anticancer medicines, immunosuppressants or biologic therapies
• Use of strong CYP3A4 inhibitors or inducers, certain antibiotics, antifungals or antiepileptics that may interact with imatinib
• Use of paracetamol, anticoagulants or other medicines that may require careful monitoring with Imatib imatinib tablets

Imatinib may not be suitable during pregnancy, and effective contraception is usually recommended during treatment and for a period afterwards, as advised by your doctor.
Breastfeeding is often discouraged while taking Imatib. Your specialist will set an appropriate monitoring schedule in your case.

Imatinib Side Effects

Common side effects

Many patients experience side effects when starting Imatib imatinib tablets, especially during the first months of treatment. Common reactions may include:

• Nausea, mild vomiting or stomach discomfort
• Diarrhea or, in some cases, constipation
• Fluid retention with swelling of ankles, legs or around the eyes
• Muscle cramps, bone pain or joint discomfort
• Fatigue, weakness or general tiredness
• Mild skin rash or itching

These side effects are often manageable with supportive care or dose adjustments, but you should report persistent or troublesome symptoms to your oncology team.

Serious side effects

Some side effects of imatinib are less common but more serious and require urgent medical attention. Serious reactions may include:

• Marked fluid retention with sudden weight gain, worsening shortness of breath or pronounced leg swelling
• Signs of severe liver problems, such as yellowing of the skin or eyes, dark urine, pale stools or intense upper abdominal pain
• Severe abdominal pain, bloody stools or vomiting blood, which may indicate serious gastrointestinal issues
• Significant changes in blood counts, with fever, frequent infections, unusual bruising or prolonged bleeding
• Severe skin reactions, widespread rash, blistering or involvement of the mouth or eyes

If you experience any of these serious symptoms while taking Imatib 100 mg, seek immediate medical care and contact your specialist as soon as possible.

Storage

• Store Imatib 100 mg tablets at room temperature, usually below 25 °C, in a dry place away from direct sunlight and excess heat.
• Keep the tablets in their original blisters and carton until use to protect them from moisture and light.
• Keep Imatib imatinib tablets out of the sight and reach of children and pets.
• Do not use the medicine after the expiry date printed on the packaging.

Ask your pharmacist or follow local regulations for safe disposal of unused or expired imatinib tablets.

Why Buy from Generic Meds Mart

Generic Meds Mart focuses on providing reliable access to essential oncology medicines such as
Imatib 100 mg imatinib tablets at fair prices in USD.
We work only with licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a documented export track record.

When you buy Imatib 100 mg online from Generic Meds Mart, you benefit from:

• Competitive pricing on generic imatinib tablets compared with many local pharmacies
• Discreet, plain packaging designed to protect your privacy during shipping
• Tracked international delivery options to many destinations
• Clear, structured product information to support discussions with your haematologist or oncologist
• Customer support available to assist with ordering, payment and shipping questions

Our goal is to help you maintain continuity of prescribed targeted therapy with transparent conditions and professional handling of each order.

Order Now

Imatib 100 mg imatinib tablets are prescription-only anticancer medicines and must be used strictly under the supervision of a haematologist or oncologist.
Before you order Imatib 100 mg online, ensure that you have a valid prescription or written treatment plan specifying imatinib, the required daily dose and intended duration of therapy.

Select Imatib 100 mg (1 pack / 10 tablets), choose the appropriate quantity, add Imatib to your cart and complete the secure checkout process.
Your order will be processed, packed discreetly and shipped with tracking where available.

Generic Meds Mart does not provide diagnosis or personalised medical advice. All treatment decisions, dose changes and monitoring remain the responsibility of your oncology team.

Alsatinib 100 mg Dasatinib Tablets (1 bottle – 30 tablets)

At a Glance

Generic Name: Dasatinib

Brand Name: Alsatinib 100 mg

Strength & Pack Size: 100 mg tablets, 1 bottle – 30 tablets

Dosage Form & Route: Oral film-coated tablets taken by mouth

Therapeutic Class: BCR-ABL tyrosine kinase inhibitor (TKI)

Primary Indications: Chronic myeloid leukemia (CML) and Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL), as per local label

Usual Adult Dose: As directed by your haematologist or oncologist based on indication and official prescribing information

Mode of Action: Inhibits BCR-ABL and related kinases that drive leukemic cell proliferation and survival

Key Benefits: Targeted therapy option in CML and Ph+ ALL, used within modern haematology treatment protocols

Precautions: Requires specialist supervision, regular blood tests, ECG and careful review of comorbidities and co-medications

Storage: Store below 25 °C in the original bottle, tightly closed and protected from moisture and light

Product Description

Alsatinib 100 mg is a dasatinib-based oral tyrosine kinase inhibitor (TKI) used as part of targeted haematology therapy in selected patients with chronic myeloid leukemia (CML) and Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL). Dasatinib is designed to inhibit BCR-ABL and certain other kinases that are abnormally active in these leukemias, and has become an important component of modern treatment strategies alongside other TKIs and disease-monitoring techniques.

Each bottle of Alsatinib 100 mg dasatinib tablets contains 30 film-coated tablets, providing a convenient supply for once-daily or protocol-defined dosing schedules. The exact use of Alsatinib 100 mg depends on your diagnosis, disease phase, prior treatments and local prescribing information. It is only prescribed by experienced haematologists or oncologists familiar with BCR-ABL–positive leukemias, molecular monitoring and the safety profile of dasatinib.

Generic Meds Mart supplies Alsatinib 100 mg dasatinib tablets in original manufacturer packaging sourced from licensed oncology and haematology distributors. Bottles and cartons display the brand name, strength, generic name, tablet count, batch number, expiry date and storage instructions so hospital pharmacies, clinics and patients can verify the product. Orders are dispatched in neutral outer packaging that does not mention leukemia or targeted therapy, maintaining privacy while preserving full batch traceability. Our role is focused on access and logistics; all clinical decisions remain with your specialist team.

Key Uses

Alsatinib 100 mg dasatinib tablets are used in the management of BCR-ABL–positive leukemias where a tyrosine kinase inhibitor has been recommended. Depending on the local label, guidelines and treating physician’s judgment, Alsatinib may be used in:

• Chronic myeloid leukemia (CML) in chronic, accelerated or blast phase in patients who are newly diagnosed or who are intolerant of, or resistant to, prior therapy with other TKIs.
• Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL) as part of combination treatment regimens and longer-term maintenance protocols according to specialist protocols.

The decision to use Alsatinib 100 mg is based on a careful assessment of your disease phase, BCR-ABL status, prior treatment history, co-existing health conditions and potential interactions with other medicines. It is not intended for general use in other cancers or haematologic disorders unless explicitly specified in your local prescribing information and specialist guidelines.

How Dasatinib Works in Chemotherapy

Dasatinib, the active ingredient in Alsatinib 100 mg, is a second-generation BCR-ABL tyrosine kinase inhibitor. In CML and Ph+ ALL, the BCR-ABL fusion protein drives uncontrolled leukemic cell growth through persistent kinase signalling. Dasatinib binds to the ATP-binding site of BCR-ABL and related kinases, inhibiting their activity and thereby interrupting key downstream pathways that promote proliferation and survival of leukemic cells.

By blocking BCR-ABL kinase signalling, dasatinib can reduce the leukemic cell burden, support restoration of more normal blood cell production and help patients achieve hematologic, cytogenetic and molecular responses. Dasatinib also has activity against other kinases, which contributes both to its therapeutic effects and to some of its side effects. Because responses and tolerability vary between individuals, Alsatinib dasatinib therapy must be closely monitored using regular blood counts, BCR-ABL testing and clinical review.

Dosage & Administration

The dose and schedule of Alsatinib 100 mg dasatinib tablets are determined by your haematologist or oncologist according to indication, disease phase, age, organ function, concomitant medications and official prescribing information. In many adult CML and Ph+ ALL regimens, dasatinib is given as a once-daily oral dose, but dose adjustments, temporary interruptions or long-term modifications may be required based on response and side effects.

Alsatinib tablets should be swallowed whole with water and should not be crushed or chewed unless your healthcare team specifically instructs you otherwise. It is important to take Alsatinib at the same time each day and to follow any directions about taking it with or without food. If you miss a dose, you should follow the advice in your patient leaflet or from your clinic and avoid taking extra tablets without medical guidance. You must not change the dose or stop dasatinib on your own; any modifications should be supervised by your specialist, who will use blood tests and molecular monitoring to guide decisions.

Precautions

Before starting Alsatinib 100 mg, your medical team will review your full medical history, including heart and lung function, liver and kidney status, risk of bleeding, prior or current fluid accumulation around the lungs (pleural effusion) and any previous TKI exposure. Dasatinib can interact with other medicines, particularly those that affect liver enzymes or gastric pH, so it is essential to provide a complete list of prescription drugs, over-the-counter products and herbal supplements to your care team.

Regular monitoring is required during Alsatinib therapy and typically includes blood counts, liver and kidney function tests, ECGs and, in some cases, chest imaging to assess for fluid accumulation. Women and men of childbearing potential are usually advised to use effective contraception during dasatinib treatment and for a period after it ends, because targeted anticancer medicines may harm a developing baby. Breastfeeding is generally not recommended while taking dasatinib.

Your specialist will explain which precautions apply in your situation.

Dasatinib Side Effects

Common side effects

Common dasatinib side effects can include headache, fatigue, nausea, diarrhoea, decreased appetite, mild abdominal discomfort, rash or dry skin, mild bleeding or bruising, and musculoskeletal pain. Some patients experience fluid retention such as ankle swelling, periorbital puffiness or mild weight gain. Blood tests may show reductions in white cells, red cells or platelets, as well as mild changes in liver function or electrolytes.

These effects are often manageable with supportive medications, careful monitoring and, in some cases, dose adjustments or short treatment interruptions. It is important to report any new or troublesome symptoms to your haematology team promptly so they can decide whether supportive care, additional tests or a change in dasatinib dosage is needed.

Serious side effects

Although less common, serious dasatinib adverse effects require urgent medical attention. These may include severe myelosuppression with high risk of infection or bleeding, significant fluid accumulation around the lungs (pleural effusion) or heart, shortness of breath, chest pain, serious bleeding events, marked prolongation of the QT interval on ECG, sudden palpitations, severe liver injury or other organ complications.

Warning signs that should prompt immediate medical review include high fever, chills, persistent cough, increasing breathlessness, chest pain, rapid or irregular heartbeat, severe bleeding, black stools, vomiting blood, sudden confusion, severe abdominal pain, yellowing of the skin or eyes, or marked swelling. If any of these occur while taking Alsatinib 100 mg dasatinib, you should seek emergency care and inform clinicians that you are on a BCR-ABL tyrosine kinase inhibitor.

Storage

Alsatinib 100 mg dasatinib tablets should be stored at room temperature, generally below 25 °C, in their original bottle with the cap tightly closed to protect from moisture and light. Do not transfer tablets to unlabelled containers and keep them out of sight and reach of children and pets. Do not use Alsatinib after the expiry date printed on the carton and bottle. Any unused or expired dasatinib tablets should be returned to a pharmacy or disposed of in line with local guidance for cytotoxic or targeted anticancer medicines and not thrown into household rubbish or wastewater.

Why Buy from Generic Meds Mart

Generic Meds Mart is focused on supporting access to essential targeted therapies such as Alsatinib 100 mg dasatinib tablets, especially in regions where local supply, pricing or distribution may be challenging. We work only with licensed manufacturers and authorised distributors that follow recognised quality standards and maintain full batch and expiry traceability. By supplying Alsatinib in sealed original packaging, we help clinics and pharmacies verify that the correct brand, strength and batch have been delivered.

All Alsatinib 100 mg orders placed through Generic Meds Mart are processed in USD using secure online checkout. Shipments are prepared in neutral outer packaging without references to leukemia or chemotherapy to protect privacy. Where available, tracked delivery options help patients and haematology teams plan treatment cycles and refills in advance, reducing the risk of interruptions caused by supply issues. Our role is strictly logistical; the choice to use dasatinib, the dose schedule and any treatment modifications are the responsibility of your specialist team.

Order Now

Before you buy Alsatinib 100 mg dasatinib tablets online from Generic Meds Mart, you should already have a confirmed diagnosis of CML or Ph+ ALL, documented BCR-ABL positivity and a written treatment plan from your haematologist or oncologist that specifically includes dasatinib, dose, monitoring strategy and expected duration. Your team will explain how Alsatinib fits alongside other parts of your care such as additional medicines, molecular testing and supportive treatments.

Once this plan is in place, you can select Alsatinib 100 mg, choose the number of bottles that correspond to your specialist’s prescription and complete secure checkout in USD. You should never start, stop or adjust dasatinib without direct medical advice. If you develop new or worsening symptoms such as fever, breathlessness, chest pain, rapid heartbeat, severe bleeding, marked swelling or confusion during treatment, you should seek urgent medical help and inform your care team. Generic Meds Mart exists to support safe, discreet and verifiable supply of Alsatinib 100 mg dasatinib tablets, while all clinical decisions about your leukemia treatment remain with your treating specialists.

FAQ about Alsatinib (Dasatinib)

Q1: What types of leukemia is Alsatinib 100 mg used for?

Alsatinib 100 mg contains dasatinib, a BCR-ABL tyrosine kinase inhibitor used in chronic myeloid leukemia (CML) and Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL) according to local prescribing information and specialist guidelines.

Q2: Will I need regular blood tests while taking Alsatinib?

Yes. Regular blood tests are essential during dasatinib therapy to monitor blood counts, liver and kidney function and to check for potential side effects. In addition, molecular tests to measure BCR-ABL levels are often used to assess how well your leukemia is responding to treatment.

Q3: Can I take antacids or acid-reducing medicines with Alsatinib?

Some acid-reducing medicines can affect the absorption of dasatinib. You should tell your haematology team about any antacids, proton pump inhibitors or H2 blockers you use. Your doctors may adjust the timing or choose alternatives to avoid reducing dasatinib exposure.

Q4: Is it safe to become pregnant while on dasatinib?

Dasatinib can be harmful to a developing baby, and pregnancy is generally not recommended while taking Alsatinib 100 mg. Effective contraception is usually required during treatment and for a period after stopping the medicine. If you are pregnant, planning pregnancy or your partner may become pregnant, you must discuss this with your specialist before starting or continuing dasatinib.

Q5: What should I do if I feel short of breath or develop a persistent cough on Alsatinib?

Shortness of breath or persistent cough can be signs of conditions such as pleural effusion or other lung issues associated with dasatinib. If you notice breathing difficulties, new chest discomfort or unexplained cough, you should contact your haematology team promptly or seek emergency care and ensure clinicians know you are taking Alsatinib 100 mg dasatinib.